Intrinsiqs

Is Lexicon Pharmaceuticals, Inc. overvalued?

Lexicon Pharmaceuticals, Inc. (LXRX) — key valuation metrics and fundamentals.

No verdict
Price
$1.79
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$797.0M
Dividend yield
0.0%
Return on equity
-38.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares LXRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.